Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Reception and Implementation of the Japanese Grant of over USD 4 million to 14 Governmental Hospitals

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani met this morning at his office in Bir Hassan with the Japanese Ambassador H.E. Matahiro Yamaguchi to celebrate the completion of the project of USD 4.289.000 Japanese grant aimed at improving 14 government hospitals in Lebanon; in Beirut: Rafic Hariri University Hospital, In Mount-Lebanon: Siblin, Shahar Gharbi, Daher El Bachek and Bouwar, North Lebanon: El Qoubbeh, Halba, and Sir Danniyeh, Beqaa: Zahleh, Baalbeck, Hermel and Rachaya and in South Lebanon: Marjaoun and Hasbaya.

The meeting was followed by a press conference held by Hasbani and the Japanese Ambassador in the presence of directors of the government hospitals that received the Japanese grant.

Arbid

The advisor to the Minister of Public Health Dr. Bahij Arbid noted that the grant aims at “enhancing the quality of services provided in the government hospitals” as he thanked Minister Hasbani who formed a committee for soft loans and grants, the Japanese Embassy and the action team at the Ministry.

Yamaguchi

The Japanese ambassador stated that Lebanon is one of the best countries in the region as to health care services. However, the Lebanese health care sector is trying to cope with the increasing medical needs of the Lebanese citizens and refugees. For this reason, Japan decided to support the Lebanese Ministry of Public Health with an emergency grant amounting to USD 5 million in order to provide 14 government hospitals with Japanese advanced equipment.

Hasbani

Hasbani thanked Japan for “its interest in the Lebanese hospitalization sector”.

"Many more hospitals benefit and will benefit from other grants provided by the Kuwaiti fund for example, which will focus on improving and equipping the emergency departments, in addition to a part of the world bank grant that will be allocated to the government hospitals as part of the financial project we secured this year,” Hasbani noted.
    1
ATC Name B/G Ingredients Dosage Form Price
S01ED51 XALACOM B Timolol (maleate) - 6.8mg/ml, Latanoprost - 50?g/ml Drops solution 510,660 L.L
S01EE01 XALAPROST G Latanoprost - 0.005% w/v 0.005% w/v Drops solution 421,967 L.L
S01EE01 XALATAN B Latanoprost - 50mcg/ml 50mcg/ml Drops solution 704,173 L.L
N05AX12 XALIPRO G Aripiprazole - 10mg 10mg Tablet 2,123,271 L.L
N05AX12 XALIPRO G Aripiprazole - 15mg 15mg Tablet 2,418,917 L.L
N05AX12 XALIPRO G Aripiprazole - 5mg 5mg Tablet 1,746,995 L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule 347,644,061 L.L
L01ED01 XALKORI B Crizotinib - 200mg 200mg Capsule 347,644,061 L.L
N05BA12 XANAX B Alprazolam - 0.5mg 0.5mg Tablet 477,064 L.L
B01AF01 XARELTO B Rivaroxaban - 2.5mg 2.5mg Tablet, film coated 4,045,168 L.L
B01AF01 XARELTO B Rivaroxaban - 15mg 15mg Tablet, film coated 4,440,862 L.L
B01AF01 XARELTO B Rivaroxaban - 20mg 20mg Tablet, film coated 4,440,862 L.L
B01AF01 XARELTO B Rivaroxaban - 10mg 10mg Tablet, film coated 1,588,892 L.L
G04CA01 XATRAL XL B Alfuzosin HCl - 10mg 10mg Tablet, prolonged release 1,061,636 L.L
B01AF01 XAVIRAN G Rivaroxaban - 15mg 15mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 20mg 20mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 10mg 10mg Tablet, film coated 606,649 L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet 80,685,473 L.L
L04AA29 XELJANZ XR B Tofacitinib - 11mg 11mg Tablet, extended release 78,687,316 L.L
L01BC06 XELODA B Capecitabine - 500mg 500mg Tablet, film coated 17,946,398 L.L
D07AC13 XEMADERM G Mometasone furoate - 0.1% 0.1% Cream 335,961 L.L
A08AB01 XENICAL B Orlistat - 120mg 120mg Capsule 4,036,903 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 100 units LD50 100 units LD50 Injectable powder for solution 20,517,541 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 50 units LD50 50 units LD50 Injectable powder for solution 11,920,109 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 1,308,903 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 686,704 L.L
J01DD15 XEVANEER G Cefdinir - 300mg 300mg Capsule 1,350,562 L.L
M05BX04 XGEVA BioTech Denosumab - 120mg 120mg Injectable solution 33,545,669 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026